The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

Multidisciplinary Clinical Case Study

Two Cases of Mistaken Identity: Neuroendocrine Tumors for Primary or Metastatic Breast Cancer

Authors: Adnan Rajeh, MD, Faisal Hussein, MD, Naman Siddique, MD, Manaf Ubaidat, MD, Priscilla Crivellaro, MD, Daryl Ramsewak, MD, Michael Sanatani, MD

Abstract

There are similarities between neuroendocrine tumors (NET) and primary breast cancers. A misdiagnosis can significantly affect prognosis and patient treatment plans, leading to potential catastrophic effects on patient care. In this study, we look at two cases in which NET was misdiagnosed as a primary breast cancer, in the breast in one case, and as metastatic breast cancer in the liver in the other case. The goals of this study were to highlight the pathological overlap between primary breast cancer with NET features and neuroendocrine tumors and the differences between their radiological appearances and to suggest steps to prevent this misdiagnosis from occurring, highlighting both the utility of informed clinical suspicion and timed imaging and pathology reviews.

 
Posted in: Breast Cancer21

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Barakat MT, Meeran K, Bloom SR. Neuroendocrine tumours. Endocr Relat Cancer 2004;11: 1–18.
 
2. Mohanty S, Kim S, DeLair D, et al. Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation. Mod Pathol 2016;29:788–798.
 
3. Martinez EO, Jorns JM, Kong AL, et al. Primary breast neuroendocrine tumors: an analysis of the National Cancer Database. Ann Surg Oncol 2022;29:6339–6346.
 
4. Amin AL, Kong AL. Metastatic neuroendocrine tumor found on screening mammogram. WMJ 2011;110:140–143, 145.
 
5. WHO Classification of Tumours Editorial Board. Breast Tumours. WHO Classification of Tumours, 5th ed. Geneva: World Health Organization; 2019.
 
6. Gulpinar B, Peker E, Kul M, et al. Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features? Abdom Radiol (NY) 2019;44:2147–2155. doi: 10.1007/s00261-019-01963-y.
 
7. Ozaki K, Higuchi S, Kimura H, et al. Liver metastases: correlation between imaging features and pathomolecular environments. Radiographics 2022;42:1994–2013. doi:10.1148/rg. 220056.
 
8. Pesapane F, Downey K, Rotili A, et al. (2020). Imaging diagnosis of metastatic breast cancer. Insights Imaging 2020;11:79. doi.org/10.1186/s13244-020-00885-4.
 
9. Pandit S, Annamaraju P, Bhusal K. Carcinoid syndrome. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2022.
 
10. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999;340:858–868.
 
11. Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26:3063–3072.
 
12. Klimstra DS. Neuroendocrine neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, et al, eds., WHO Classification of Tumours of the Digestive System, 4th ed. Geneva: World Health Organization; 2010: 322–326.
 
13. Policeni F, Pakalniskis B, Yang L. Occult primary neuroendocrine tumor metastasis to the breast detected on screening mammogram. J Clin Imaging Sci 2016;6:41. doi: 10.4103/2156- 7514.191439.
 
14. Sangha Brar J, Lo L, Wong J. Metastases to the breast: great radiological mimicker of primary breast carcinoma and a forgotten entity. A case series of three patients and a review of the literature. BJR Case Rep 2017;3:20160137. doi: 10.1259/bjrcr.20160137.
 
15. Mun SH, Ko EY, Han BK, et al. Breast metastases from extramammary malignancies: typical and atypical ultrasound features.Korean J Radiol 2014;15:20–28. doi: 10.3348/kjr.2014.15.1.20.
 
16. Economopoulou P, Chrysikopoulou A, Goula K, et al. Breast metastasis from neuroendocrine carcinoma of the lung: a case report and review of the literature. Case Rep Oncol 2021;13: 1281–1284.
 
17. Ahn S, Bhagwandin S, Reindl B, et al. Metastatic carcinoid tumor presenting as a breast mass: a case report and review of the literature. Arch Surg Oncol 2016;2:111.
 
18. Gupta C, Malani AK, Rangineni S. Breast metastasis of ilial carcinoid tumor: case report and literature review. World J Surg Oncol 2006;4:15.
 
19. Bartella L, Kaye J, Perry NM, et al. Metastases to the breast revisited: radiological– histopathological correlation. Clin Radiol 2003:524–531.
 
20. Shukla R, Pooja B, Radhika S, et al. Fine-needle aspiration cytology of extramammary neoplasms metastatic to the breast. Diagn Cytopathol 2005;32:193–197.
 
21. Lee AH. The histological diagnosis of metastases to the breast from extramammary malignancies. J Clin Pathol 2007;60:1333–1341.
 
22. Babu KS, Roberts F, Bryden F, et al. Metastases to breast from primary lung cancer. J Thorac Oncol 2009;4:540–542.
 
23. Crona J, Granberg D, Norlén O, et al. Metastases from neuroendocrine tumors to the breast are more common than previously thought. A diagnostic pitfall? World J Surg 2013;37: 1701–1706.